Contraste
Acessibility 
Average Target Price – R$ 4,16
| Consensus | 2025E | 2026E | 2027E |
|---|---|---|---|
| Net sales (R$ million) | R$ 29,069 | R$ 30,616 | R$ 32,122 |
| Gross margin (%) | 30.8% | 31.3% | 30.9% |
| Adjusted EBITDA (R$ million) | R$ 2,490 | R$ 2,767 | R$ 2,954 |
| Financial result (R$ million) | -R$ 3,021 | -R$ 2,779 | -R$ 2,596 |
| Net income (R$ million) | -R$ 1,228 | -R$ 692 | -R$ 545 |
TARGET PRICE (Sell) – R$ 3,80
| Banco do Brasil projections | 2025E | 2026E |
|---|---|---|
| Net sales (R$ million) | R$ 28,617 | R$ 30,336 |
| Gross margin (%) | 29.3% | 30.9% |
| Adjusted EBITDA (R$ million) | R$ 2,075 | R$ 2,230 |
| Financial result (R$ million) | R$ (2,540) | R$ (2,509) |
| Net income (R$ million) | R$ (1,095) | R$ (1,008) |
TARGET PRICE (Sell) – R$ 2,50
| BofA Merrill Lynch projections | 2025E | 2026E | 2027E |
|---|---|---|---|
| Net sales(R$ million) | R$ 29,213 | R$ 30,217 | R$ 30,068 |
| Gross margin (%) | – | – | – |
| Adjusted EBITDA (R$ million) | – | – | 2,713 |
| Financial result (R$ million) | – | – | – |
| Net income (R$ million) | -R$ 1,546 | -R$ 969 | -R$ 675 |
TARGET PRICE (Neutral) – R$ 9,00
| Bradesco projections | 2024E | 2025E |
|---|---|---|
| Net sales (R$ million) | R$ 30,512 | R$ 32,209 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | R$ 3,008 | R$ 3,207 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | – | R$ 44 |
TARGET PRICE (Neutral) – R$ 3,00
| BTG Pactual projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 28,637 | R$ 30,108 |
| Gross margin (%) | 31.6% | 32.1% |
| Adjusted EBITDA (R$ million) | R$ 2,561 | R$ 2,859 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 754 | -R$ 154 |
TARGET PRICE (Neutral) – R$ 4,00
| Genial projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 29,715 | R$ 30,509 |
| Gross margin (%) | 31.1% | 31.6% |
| Adjusted EBITDA (R$ million) | R$ 2,692 | R$ 2,933 |
| Financial result (R$ million) | -R$ 2,326 | -R$ 2,141 |
| Net income (R$ million) | -R$ 602 | -R$ 327 |
TARGET PRICE (Sell) – R$ 3,20
| Goldman Sachs projections | 2025E | 2026E | 2027E |
|---|---|---|---|
| Net sales (R$ million) | R$ 29,047 | R$ 30,584 | R$ 32,250 |
| Gross margin (%) | – | – | – |
| Adjusted EBITDA (R$ million) | R$ 2,481 | R$ 2,666 | R$ 2,877 |
| Financial result (R$ million) | – | – | – |
| Net income (R$ million) | -R$ 1,540 | -R$ 1,174 | -R$ 702 |
TARGET PRICE (Sell) - -
| Morgan Stanley projections | 2025E | 2026E | 2027E |
|---|---|---|---|
| Net sales(R$ million) | R$ 28,963 | R$ 30,759 | R$ 32,516 |
| Gross margin (%) | 30.9% | 31.0% | 31.0% |
| Adjusted EBITDA (R$ million) | R$ 2,290 | R$ 2,469 | R$ 2,751 |
| Financial result (R$ million) | -R$ 3,279 | -R$ 2,953 | -R$ 2,217 |
| Net income (R$ million) | -R$ 1,418 | -R$ 1,116 | -R$ 880 |
TARGET PRICE (Sell) – R$ 4,00
| Safra projections | 2025E | 2026E | 2027E |
|---|---|---|---|
| Net sales (R$ million) | R$ 28,949 | R$ 30,322 | R$ 31,982 |
| Gross margin (%) | – | – | – |
| Adjusted EBITDA (R$ million) | R$ 2,502 | R$ 2,788 | R$ 3,072 |
| Financial result (R$ million) | – | – | – |
| Net income (R$ million) | -R$ 1,143 | -R$ 675 | -R$ 421 |
TARGET PRICE (Neutral) – R$ 3,90
| Santander projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 28,674 | R$ 30,126 |
| Gross margin (%) | 31.5% | 31.5% |
| Adjusted EBITDA (R$ million) | R$ 2,552 | R$ 2,976 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | – R$ 1,020 | – R$ 527 |
TARGET PRICE (Neutral)) – R$ 4.00
| XP projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | – | – |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | – | – |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | – | – |
